Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2010

Nov 12, 2010

30071_dirs_2010-11-12_16d4bd44-d235-4e6b-bcb2-e3f77908c46d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-11-10

Reporting Person: Gallahue Kieran (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-11-10 ResMed Common Stock M 8000 $12.468 Acquired 71589.794 Direct
2010-11-10 ResMed Common Stock S 8000 $33.097 Disposed 63589.794 Direct
2010-11-10 ResMed Common Stock M 16000 $15.52 Acquired 79589.794 Direct
2010-11-10 ResMed Common Stock S 16000 $33.131 Disposed 63589.794 Direct
2010-11-11 ResMed Common Stock F 6668 $33.70 Disposed 56921.794 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-11-10 ResMed Common Stock Options $12.468 M 8000 Disposed 2015-01-20 ResMed Common Stock (8000) Direct
2010-11-10 ResMed Common Stock Options $15.52 M 16000 Disposed 2015-11-20 ResMed Common Stock (16000) Direct
2010-11-11 ResMed Common Stock Options $33.70 A 100000 Acquired 2017-11-11 ResMed Common Stock (100000) Direct

Footnotes

F1: Represents first date options became exercisable.

F2: Represents first date 1/4 of the options become exerisable. Thereafter, options will continue to vest 1/4 annually until fully vested.

F3: This transaction was executed in multiple trades at prices ranging from $33.07 to $33.125. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F4: This transaction was executed in multiple trades at prices ranging from $33.10 to 33.175. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F5: Dispositon to issuer for tax withholding upon vesting of Restricted Stock Units.